Invention Grant
- Patent Title: Cell line overexpressing human CD303 antigen
-
Application No.: US15563046Application Date: 2016-03-31
-
Publication No.: US10239946B2Publication Date: 2019-03-26
- Inventor: Nathalie Fournier , Christophe De Romeuf
- Applicant: Laboratoire Francais du Fractionnement et des Biotechnologies
- Applicant Address: FR Les Ulis
- Assignee: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Current Assignee: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Current Assignee Address: FR Les Ulis
- Agency: Potomac Law Group, PLLC
- Priority: FR1552757 20150331
- International Application: PCT/EP2016/056994 WO 20160331
- International Announcement: WO2016/156449 WO 20161006
- Main IPC: C12N15/85
- IPC: C12N15/85 ; C07K16/28 ; C12N15/79

Abstract:
The invention relates to a cell line expressing the gamma chain of the FcεRI receptor and human CD303 antigen, characterized in that said cell line is transfected in a stable manner by an expression vector comprising a nucleic acid molecule coding for human CD303 antigen and having strong expression of human CD303 on the surface thereof, e.g. at least 10000 molecules of human CD303 per cell, as well as a vector or vector kit that can be used to co-express the gamma chain of the FcεRI receptor and human CD303 antigen, and different uses of the cell line of the invention.
Public/Granted literature
- US20180066060A1 Cell Line Overexpressing Human CD303 Antigen Public/Granted day:2018-03-08
Information query
IPC分类: